Egypt approves China's Sinovac coronavirus vaccine for emergency use

CAIRO, April 26 (Reuters) - Egypt's drug authority said on Monday it had granted approval to China's Sinovac (SVA.O) coronavirus vaccine for emergency use.
Egypt has so far approved and received shipments of the Sinopharm and AstraZeneca vaccines, and has said it is preparing to produce up to 80 million doses of the Sinovac vaccine locally.
It has also granted approval to Russia's Sputnik vaccine.
Reporting by Mahmoud Mourad
Writing by Aidan Lewis
Editing by Leslie Adler
Our Standards: The Thomson Reuters Trust Principles.